Articles and resources on breast cancer for patients, caregivers, and family members
Breast CancerPalliative Care
For patients with metastatic breast cancer, “Involving palliative care as an active member of your oncology team early on is one of the smartest things you can do,” says national expert and breast cancer survivor Lillie Shockney.
For those dealing with metastatic breast cancer, national expert and breast cancer survivor Lillie Shockney stresses the importance of celebrating milestone events and joyful moments during treatment.
Breast CancerFDA NewsNewsworthy
The CDK4/CDK6 inhibitor Verzenio received a new indication, for use alone or in combination with an aromatase inhibitor, as initial therapy in women with HR-positive, HER2-negative advanced or metastatic breast cancer.
A national advocacy program trains patients with metastatic breast cancer to educate the public about the special needs of patients with advanced breast cancer.
Breast CancerCancer BiomarkersCancer Screening
What Are Biomarkers in Breast Cancer, and How Do They Affect My Treatment? Interview with Daniel F. Hayes, MD, FACP, FASCO
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.
Breast CancerPatient Advocacy
Musa Mayer, breast cancer survivor and advocate, was recently recognized for her 25 years of advocacy on behalf of patients with advanced breast cancer. Read Musa’s inspiring story.
Living Beyond Breast Cancer to Host 12th Annual National Metastatic Breast Cancer Conference in Philadelphia, April 20-22
Press Releases – April 10, 2018
Hundreds of people with metastatic breast cancer and their caregivers from across the country will attend the 2018 Conference on Metastatic Breast Cancer in Philadelphia on April 20–22, 2018, hosted by Living Beyond Breast Cancer.
Breast CancerNewsworthyWeb Exclusives
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
Web Exclusives – April 7, 2018
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.
Page 2 of 6
Results 11 - 20 of 57
Results 11 - 20 of 57